NCT00614900

Brief Summary

The prevalence of an increased pulmonary blood pressure amongst patients with chronic obstructive pulmonary disease (COPD)is unclear. So is the impact of abnormal pulmonary blood pressure on symptoms. The aim of this study is to determine the prevalence of an increased pulmonary blood pressure in 200 patients with COPD. Furthermore we will investigate if lung function test results and blood tests can predict an increased pulmonary blood pressure, and explore whether COPD patients with a high pulmonary blood pressure have more symptoms that their co-patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
117

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2008

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2008

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 13, 2008

Completed
17 days until next milestone

Study Start

First participant enrolled

March 1, 2008

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
Last Updated

September 18, 2012

Status Verified

September 1, 2012

Enrollment Period

3 years

First QC Date

January 31, 2008

Last Update Submit

September 17, 2012

Conditions

COPDPulmonary Hypertension

Keywords

COPDpulmonary hypertensionNT-proBNP6 minutes walk test

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients have been admitted to hospital with an exacerbation in COPD in 2006.

You may qualify if:

  • Diagnosis of COPD
  • Prior admittance to hospital with exacerbation in COPD
  • Informed consent

You may not qualify if:

  • Exacerbation in COPD less than 6 weeks before examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of pulmonary diseases, Aarhus Sygehus

Aarhus, 8000, Denmark

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveHypertension, Pulmonary

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Ole Hilberg, Md, Dr.med.

    Aarhus Universitetshospital, Aarhus Sygehus

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 31, 2008

First Posted

February 13, 2008

Study Start

March 1, 2008

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

September 18, 2012

Record last verified: 2012-09

Locations

DK(1)